Top Markets
Coin of the day
Immunotech Biopharm Ltd Immunotech Biopharm Ltd

Immunotech Biopharm Ltd

6978
Rang in aandelen #27803
Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in... Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in cellular immunotherapy. Its primary activities involve the investigation, development, and market introduction of T cell-based immunotherapy solutions for various cancers within the People's Republic of China. The company's flagship product, EAL, is a multi-target cellular immunotherapy currently undergoing Phase II clinical trials for the purpose of preventing liver cancer recurrence after surgery. Furthermore, Immunotech Biopharm is conducting both preclinical and clinical research on EAL for its potential use in treating lung cancer, glioma, gastric cancer, and colorectal cancer. Other pipeline assets include the 6B11-OCIK injection, which is in Phase I trials for ovarian cancer; the CAR-T-19 injection product, targeting B-cell acute lymphoblastic leukaemia; and a range of TCR-T cell products designed for solid tumor treatment. Established in 2006, the company's main office is located in Beijing, China.
Aandeelprijs
$0.0492516
Marktkapitalisatie
$30.41M
Verandering (1 dag)
1.32%
Verandering (1 jaar)
-91.28%
Land
CN
Handel Immunotech Biopharm Ltd (6978)

Categorie

Aandelsplitsingen voor Immunotech Biopharm Ltd (6978)
Het aandeel Immunotech Biopharm Ltd (symbool: 6978) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 20, 2026.
Eén aandeel 6978 dat vóór Aug 20, 2026 werd gekocht, staat nu gelijk aan 0 aandelen 6978.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH